Literature DB >> 4352583

Mutants of nonproducer cell lines transformed by murine sarcoma viruses. I. Induction, isolation, particle production, and tumorigenicity.

M Hatanaka, R Klein, R Toni, J Walker, R Gilden.   

Abstract

A variety of cell mutants were obtained by a single 5'-bromodeoxyuridine (BrdU) treatment of an nonproducer (NP) cell line transformed by the Kirsten strain of murine sarcoma virus (Ki-MSV). Isolation procedures of these cell See PDF for Structure mutants are described. The cell mutants obtained were classified by tumorigenic potential and shedding of Type C virus particles. The cell mutants were classified into four groups: (A) tumorigenic, without particles; (B) tumorigenic, with Type C particles; (C) nontumorigenic, without particles; and (D) nontumorigenic, with Type C particles. The tumorigenic cell lines showed variability in morphology with both flat and typical transformed appearing cell lines showing equal transplantability.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4352583      PMCID: PMC2139394          DOI: 10.1084/jem.138.2.356

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  3 in total

1.  Development of 3T3-like lines from Balb-c mouse embryo cultures: transformation susceptibility to SV40.

Authors:  S A Aaronson; G J Todaro
Journal:  J Cell Physiol       Date:  1968-10       Impact factor: 6.384

2.  Tumorigenicity, immunogenicity, and virus production in mouse melanoma cells treated with 5-bromodeoxyuridine.

Authors:  S Silagi; D Beju; J Wrathall; E Deharven
Journal:  Proc Natl Acad Sci U S A       Date:  1972-11       Impact factor: 11.205

3.  Antigenic properties of murine sarcoma virus-transformed BALB-3T3 nonproducer cells.

Authors:  J R Stephenson; S A Aaronson
Journal:  J Exp Med       Date:  1972-03-01       Impact factor: 14.307

  3 in total
  12 in total

1.  Selection of revertants of Kirsten sarcoma virus transformed nonproducer BALB-3T3 cells.

Authors:  B Ozanne; A Vogel
Journal:  J Virol       Date:  1974-08       Impact factor: 5.103

2.  Activation of an endogenous mouse type C virus by ultraviolet-irradiated herpes simplex virus types 1 and 2.

Authors:  B Hampar; S A Aaronson; J G Derge; M Chakrabarty; S D Showalter; C Y Dunn
Journal:  Proc Natl Acad Sci U S A       Date:  1976-02       Impact factor: 11.205

3.  Detection of a transformation-related antigen in chemically induced sarcomas and other transformed cells of the mouse.

Authors:  A B DeLeo; G Jay; E Appella; G C Dubois; L W Law; L J Old
Journal:  Proc Natl Acad Sci U S A       Date:  1979-05       Impact factor: 11.205

4.  Comparison of antitumor activity of Lactobacillus casei with other bacterial immunopotentiators.

Authors:  N Yasutake; M Ohwaki; T Yokokura; M Mutai
Journal:  Med Microbiol Immunol       Date:  1984       Impact factor: 3.402

5.  Species and interspecies radioimmunoassays for rat type C virus p30: interviral comparisons and assay of human tumor extracts.

Authors:  H P Chapman; M H White; R Rahman; R V Gilden
Journal:  J Virol       Date:  1975-01       Impact factor: 5.103

6.  Sarcoma and helper-specific RNA tumor virus subunits in transformed nonproducer mouse cells activated to produce virus by treatment with bromodeoxyuridine.

Authors:  N Tsuchida; M S Shih; R V Gilden; M Hatanaka
Journal:  J Virol       Date:  1974-11       Impact factor: 5.103

7.  Flat revertants isolated from Kirsten sarcoma virus-transformed cells are resistant to the action of specific oncogenes.

Authors:  M Noda; Z Selinger; E M Scolnick; R H Bassin
Journal:  Proc Natl Acad Sci U S A       Date:  1983-09       Impact factor: 11.205

8.  Sarcoma-virus-related RNA sequences in normal rat cells.

Authors:  N Tsuchida; R V Gilden; M Hatanaka
Journal:  Proc Natl Acad Sci U S A       Date:  1974-11       Impact factor: 11.205

9.  Anti-tumour effect of humoral and cellular immunities mediated by a bacterial immunopotentiator, Lactobacillus casei, in mice.

Authors:  N Yasutake; M Ohwaki; M Mutai; Y Koide; T Yoshida
Journal:  Cancer Immunol Immunother       Date:  1985       Impact factor: 6.968

10.  Mutants of nonproducer cell lines transformed by murine sarcoma virus. 3. Detection and characterization of RNA specific for helper and sarcoma viruses.

Authors:  N Tsuchida; M Shih; R V Gilden; M Hatanaka
Journal:  J Exp Med       Date:  1974-07-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.